Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Passarelli MN, Barry EL, Rees JR, Mott LA, Zhang D, Ahnen DJ, Bresalier RS, Haile RW, McKeown-Eyssen G, Snover DC, Cole BF, Baron JA.

Am J Clin Nutr. 2019 Aug 10. pii: nqz160. doi: 10.1093/ajcn/nqz160. [Epub ahead of print]

PMID:
31401653
2.

Patients with breast cancer may be at higher risk of colorectal neoplasia.

Abu-Sbeih H, Ali FS, Ge PS, Barcenas CH, Lum P, Qiao W, Bresalier RS, Bhutani MS, Raju GS, Wang Y.

Ann Gastroenterol. 2019 Jul-Aug;32(4):400-406. doi: 10.20524/aog.2019.0387. Epub 2019 May 20.

3.

Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors.

Tang T, Abu-Sbeih H, Luo W, Lum P, Qiao W, Bresalier RS, Richards DM, Wang Y.

Scand J Gastroenterol. 2019 May;54(5):538-545. doi: 10.1080/00365521.2019.1594356. Epub 2019 May 13.

PMID:
31079556
4.

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.

Abu-Sbeih H, Ali FS, Wang X, Mallepally N, Chen E, Altan M, Bresalier RS, Charabaty A, Dadu R, Jazaeri A, Lashner B, Wang Y.

J Immunother Cancer. 2019 Apr 2;7(1):93. doi: 10.1186/s40425-019-0577-1.

5.

Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study.

Grizzi F, Fiorino S, Qehajaj D, Fornelli A, Russo C, de Biase D, Masetti M, Mastrangelo L, Zanello M, Lombardi R, Domanico A, Accogli E, Tura A, Mirandola L, Chiriva-Internati M, Bresalier RS, Jovine E, Leandri P, Di Tommaso L.

J Transl Med. 2019 Feb 28;17(1):61. doi: 10.1186/s12967-019-1817-3.

6.

Body mass index, calcium supplementation and risk of colorectal adenomas.

Barry EL, Lund JL, Westreich D, Mott LA, Ahnen DJ, Beck GJ, Bostick RM, Bresalier RS, Burke CA, Church TR, Rees JR, Robertson DJ, Baron JA.

Int J Cancer. 2019 Feb 1;144(3):448-458. doi: 10.1002/ijc.31803. Epub 2018 Oct 30.

PMID:
30117164
7.

Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma.

Bresalier RS.

Dig Dis Sci. 2018 Aug;63(8):2155-2162. doi: 10.1007/s10620-018-5149-6. Review.

PMID:
29948566
8.

A Goblet (Cell) Half Full: What Do We Really Know About Barrett's Esophagus-A Tribute to Emmet Keeffe.

Bresalier RS, Souza RF.

Dig Dis Sci. 2018 Aug;63(8):1985-1987. doi: 10.1007/s10620-018-5153-x. No abstract available.

PMID:
29948560
9.

Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.

Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA.

Br J Dermatol. 2018 Aug;179(2):337-344. doi: 10.1111/bjd.16571. Epub 2018 Jun 19.

10.

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial.

Crockett SD, Barry EL, Mott LA, Ahnen DJ, Robertson DJ, Anderson JC, Wallace K, Burke CA, Bresalier RS, Figueiredo JC, Snover DC, Baron JA.

Gut. 2018 Mar 1. pii: gutjnl-2017-315242. doi: 10.1136/gutjnl-2017-315242. [Epub ahead of print]

11.

Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.

Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, Johnson RL, Bresalier RS, Logsdon CD, Zhang Z, Song S.

Gastroenterology. 2018 Apr;154(5):1524-1537.e6. doi: 10.1053/j.gastro.2017.12.014. Epub 2017 Dec 21.

PMID:
29274868
12.

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.

Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S.

Br J Cancer. 2018 Jan;118(1):52-61. doi: 10.1038/bjc.2017.388. Epub 2017 Nov 14.

13.

Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.

Mirandola L, Pedretti E, Figueroa JA, Chiaramonte R, Colombo M, Chapman C, Grizzi F, Patrinicola F, Kast WM, Nguyen DD, Rahman RL, Daver N, Ruvolo P, Post SM, Bresalier RS, Chiriva-Internati M.

Oncotarget. 2017 Aug 10;8(43):74378-74390. doi: 10.18632/oncotarget.20102. eCollection 2017 Sep 26.

14.

Aspirin prevents NF-╬║B activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.

Huo X, Zhang X, Yu C, Cheng E, Zhang Q, Dunbar KB, Pham TH, Lynch JP, Wang DH, Bresalier RS, Spechler SJ, Souza RF.

Gut. 2018 Apr;67(4):606-615. doi: 10.1136/gutjnl-2016-313584. Epub 2017 Apr 25.

15.

A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.

Poneros JM, Faye AS, Barr Fritcher EG, Sen A, Anandasabapathy S, Bresalier RS, Marcon N, Turgeon DK, Appelman H, Normolle D, Morrison LE, Brenner DE, Halling KC.

Dig Dis Sci. 2017 May;62(5):1216-1222. doi: 10.1007/s10620-017-4517-y. Epub 2017 Mar 6.

16.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

17.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA.

Mol Carcinog. 2017 Aug;56(8):1977-1983. doi: 10.1002/mc.22629. Epub 2017 Mar 6.

18.

Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.

Cramer P, Bresalier RS.

Curr Gastroenterol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11894-017-0540-6. Review.

PMID:
28124291
19.

Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.

Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, Baron JA.

JAMA Oncol. 2017 May 1;3(5):628-635. doi: 10.1001/jamaoncol.2016.5917.

20.

Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults.

Rees JR, Mott LA, Barry EL, Baron JA, Bostick RM, Figueiredo JC, Bresalier RS, Robertson DJ, Peacock JL.

J Nutr. 2016 Nov;146(11):2312-2324. Epub 2016 Sep 28.

21.

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.

Ilmer M, Mazurek N, Gilcrease MZ, Byrd JC, Woodward WA, Buchholz TA, Acklin K, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS.

Breast Cancer Res. 2016 Sep 29;18(1):97. doi: 10.1186/s13058-016-0757-6.

22.

Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics.

Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS.

Cell Death Dis. 2016 Aug 11;7(8):e2337. doi: 10.1038/cddis.2016.239.

23.

Randomized controlled trials: who fails run-in?

Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL.

Trials. 2016 Jul 29;17:374. doi: 10.1186/s13063-016-1451-9.

24.

Association between adenoma location and risk of recurrence.

Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA.

Gastrointest Endosc. 2016 Oct;84(4):709-16. doi: 10.1016/j.gie.2016.02.048. Epub 2016 Mar 11.

25.

Outcome of EMR as an alternative to surgery in patients with complex colon polyps.

Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller E, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila ML, Stroehlein JR.

Gastrointest Endosc. 2016 Aug;84(2):315-25. doi: 10.1016/j.gie.2016.01.067. Epub 2016 Feb 6.

26.

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.

Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ.

Cancer Prev Res (Phila). 2015 Dec;8(12):1131-7. doi: 10.1158/1940-6207.CAPR-14-0274-T. Epub 2015 Oct 15.

27.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

28.

Risk Factors for Hemorrhoids on Screening Colonoscopy.

Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL, Baron JA.

PLoS One. 2015 Sep 25;10(9):e0139100. doi: 10.1371/journal.pone.0139100. eCollection 2015.

29.

Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).

Fedirko V, Bradshaw PT, Figueiredo JC, Sandler RS, Barry EL, Ahnen DJ, Milne GL, Bresalier RS, Baron JA.

Cancer Prev Res (Phila). 2015 Nov;8(11):1061-8. doi: 10.1158/1940-6207.CAPR-15-0212. Epub 2015 Aug 24.

30.

Natural language processing as an alternative to manual reporting of colonoscopy quality metrics.

Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA.

Gastrointest Endosc. 2015 Sep;82(3):512-9. doi: 10.1016/j.gie.2015.01.049. Epub 2015 Apr 22.

31.

Flexible sigmoidoscopy: more than a unilateral breast exam?

Bresalier RS.

Dig Dis Sci. 2015 Mar;60(3):634-8. doi: 10.1007/s10620-015-3610-3. Review. No abstract available.

PMID:
25740557
32.

CRC screening, past, present, and future: a tribute to Emmet Keeffe.

Ahnen DJ, Bresalier RS, Levin B, Kaunitz JD.

Dig Dis Sci. 2015 Mar;60(3):589-91. doi: 10.1007/s10620-015-3603-2. No abstract available.

33.

Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?

Bresalier RS, Kopetz S, Brenner DE.

Dig Dis Sci. 2015 Mar;60(3):664-71. doi: 10.1007/s10620-015-3575-2. Epub 2015 Feb 14. Review.

PMID:
25680874
34.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.

Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA.

Cancer Causes Control. 2015 Mar;26(3):377-86. doi: 10.1007/s10552-014-0513-0. Epub 2014 Dec 24.

35.

The association of age and race and the risk of large bowel polyps.

Wallace K, Burke CA, Ahnen DJ, Barry EL, Bresalier RS, Saibil F, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):448-53. doi: 10.1158/1055-9965.EPI-14-1076. Epub 2014 Dec 9.

36.

Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.

Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G.

PLoS One. 2014 Nov 6;9(11):e111914. doi: 10.1371/journal.pone.0111914. eCollection 2014.

37.

Calcium supplementation increases blood creatinine concentration in a randomized controlled trial.

Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA.

PLoS One. 2014 Oct 15;9(10):e108094. doi: 10.1371/journal.pone.0108094. eCollection 2014.

38.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389. Epub 2014 Jul 29.

39.

Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress.

Kim SJ, Lee HW, Gu Kang H, La SH, Choi IJ, Ro JY, Bresalier RS, Song J, Chun KH.

Cell Death Differ. 2014 Nov;21(11):1769-79. doi: 10.1038/cdd.2014.88. Epub 2014 Jun 27.

40.

Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.

Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH.

Oncotarget. 2014 May 30;5(10):3386-98.

41.

Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.

Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, Barry EL, Berman BP, Rice JC, Coetzee GA, Casey G.

Hum Mol Genet. 2014 Apr 15;23(8):2198-209. doi: 10.1093/hmg/ddt584. Epub 2013 Nov 20.

42.

Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial.

Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA.

Clin Infect Dis. 2013 Nov;57(10):1384-92. doi: 10.1093/cid/cit549. Epub 2013 Sep 6.

43.

The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Turner ND, Ritchie LE, Bresalier RS, Chapkin RS.

Curr Gastroenterol Rep. 2013 Sep;15(9):346. doi: 10.1007/s11894-013-0346-0. Review.

44.

Adenoma detection in patients undergoing a comprehensive colonoscopy screening.

Raju GS, Vadyala V, Slack R, Krishna SG, Ross WA, Lynch PM, Bresalier RS, Hawk E, Stroehlein JR.

Cancer Med. 2013 Jun;2(3):391-402. doi: 10.1002/cam4.73. Epub 2013 Apr 20.

45.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.

Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM.

Cancer Causes Control. 2013 Jan;24(1):47-54. doi: 10.1007/s10552-012-0088-6. Epub 2012 Oct 19.

46.

Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.

Song S, Ji B, Ramachandran V, Wang H, Hafley M, Logsdon C, Bresalier RS.

PLoS One. 2012;7(8):e42699. doi: 10.1371/journal.pone.0042699. Epub 2012 Aug 10.

47.

Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011.

Sung JJ, Ng EK, Lin JT, Ho KY, Ji JF, Sugano K, Poon RT, Chan AT, Goh KL, Han KH, Chen LL, Wu KC, Ng SS, Bresalier RS, Chan FK; Asia Pacific GI Oncology Summit Group.

J Gastroenterol Hepatol. 2012 Sep;27(9):1417-22. doi: 10.1111/j.1440-1746.2012.07194.x.

PMID:
22694174
48.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.

49.

Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.

Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT 4th, Marcon NE, Baron JA, Bresalier RS, Syngal S, Brenner DE, Boland CR, Stoffel EM.

Cancer Prev Res (Phila). 2012 Apr;5(4):574-82. doi: 10.1158/1940-6207.CAPR-11-0519. Epub 2012 Jan 18.

50.

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.

Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS.

Cell Death Differ. 2012 Mar;19(3):523-33. doi: 10.1038/cdd.2011.123. Epub 2011 Sep 23.

Supplemental Content

Loading ...
Support Center